A wrench in the works of human acetylcholinesterase: Soman induced conformational changes revealed by molecular dynamics simulations

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Bennion, Brian J ^a   Essiz, Sebnem G ^b   Lau, Edmond Y ^a   Fattebert, Jean Luc ^a   Emigh, Aiyana ^a   Lightstone, Felice C ^a  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^b KADIR HAS UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; FLUORIDE ION; SOMAN; CHOLINESTERASE INHIBITOR;

ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVE SITE; ENZYME MECHANISM; HUMAN; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PHOSPHONYLATION; PROTEIN CLEAVAGE; PROTEIN STRUCTURE; QUANTUM MECHANICS; CHEMISTRY; DRUG EFFECTS; PROTEIN CONFORMATION;

ACETYLCHOLINESTERASE; CATALYTIC DOMAIN; CHOLINESTERASE INHIBITORS; HUMANS; MOLECULAR DYNAMICS SIMULATION; PROTEIN CONFORMATION; SOMAN;

EID: 84928780851     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121092     Document Type: Article

References (93)

1. Millard CB, Koellner G, Ordentlich A, Shafferman A, Silman I, Sussman JL. Reaction products of acetylcholinesterase and VX reveal a mobile histidine in the catalytic triad. J Am Chem Soc. 1999; 121(42):9883-4.
2. Anand P, Singh B. A review on cholinesterase inhibitors for Alzheimer's disease. Arch Pharm Res. 2013; 36(4):375-99. doi: 10.1007/s12272-013-0036-3 PMID: 23435942
3. Gunnell D, Eddleston M, Phillips MR, Konradsen F. The global distribution of fatal pesticide self-poisoning: Systematic review. Bmc Public Health. 2007;7. PMID: 17233919
4. Worek F, Thiermann H. The value of novel oximes for treatment of poisoning by organophosphorus compounds. Pharmacology & Therapeutics. 2013; 139(2):249-59.
5. Silva GR, Borges I, Figueroa-Villar JD, de Castro AT. Chemical Defense: History, Warfare Agent Classification and Action of Neurotoxic Agents. Quimica Nova. 2012; 35(10):2083-91. PMID: 22815294
6. Dolgin E. Syrian gas attack reinforces need for better anti-sarin drugs. Nat Med. 2013; 19(10):1194-5. doi: 10.1038/nm1013-1194 PMID: 24100968
7. Millard CB, Kryger G, Ordentlich A, Greenblatt HM, Harel M, Raves ML, et al. Crystal structures of aged phosphonylated acetylcholinesterase: Nerve agent reaction products at the atomic level. Biochemistry. 1999; 38(22):7032-9. PMID: 10353814
8. Masson P. Evolution of and perspectives on therapeutic approaches to nerve agent poisoning. Toxicol Lett. 2011; 206(1):5-13. doi: 10.1016/j.toxlet.2011.04.006 PMID: 21524695
9. Worek F, Thiermann H, Szinicz L, Eyer P. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochemical pharmacology. 2004; 68(11):2237-48. PMID: 15498514
10. Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, et al. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science. 1991; 253(5022):872-9. PMID: 1678899
11. Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. Journal of molecular graphics. 1996; 14(1):33-8, 27-8. PMID: 8744570
12. Stone J. Efficient Library for Parallel Ray Tracing and Animation. Rolla: University of Missouri-Rolla; 1998.
13. Alisaraie L, Fels G. Molecular docking study on the "back door" hypothesis for product clearance in acetylcholinesterase. Journal of molecular modeling. 2006; 12(3):348-54. PMID: 16341717
14. Bazelyansky M, Robey E, Kirsch JF. Fractional diffusion-limited component of reactions catalyzed by acetylcholinesterase. Biochemistry. 1986; 25(1):125-30. PMID: 3954986
15. Wilson IB, Harrison MA. Turnover number of acetyl-cholinesterase. J Biol Chem. 1961; 236:2292-5. PMID: 13785664
16. Tan RC, Truong TN, Mccammon JA, Sussman JL. Acetylcholinesterase-Electrostatic Steering Increases the Rate of Ligand-Binding. Biochemistry. 1993; 32(2):401-3. PMID: 8422348
17. Shafferman A, Ordentlich A, Barak D, Kronman C, Ber R, Bino T, et al. Electrostatic Attraction by Surface-Charge Does Not Contribute to the Catalytic Efficiency of Acetylcholinesterase. Embo Journal. 1994; 13(15):3448-55. PMID: 8062821
18. Porschke D, Creminon C, Cousin X, Bon C, Sussman J, Silman I. Electrooptical measurements demonstrate a large permanent dipole moment associated with acetylcholinesterase. Biophys J. 1996; 70(4):1603-8. PMID: 8785319
19. Wlodek ST, Shen TY, McCammon JA. Electrostatic steering of substrate to acetylcholinesterase: Analysis of field fluctuations. Biopolymers. 2000; 53(3):265-71. PMID: 10679631
20. Radic Z, Reiner E, Taylor P. Role of the peripheral anionic site on acetylcholinesterase: inhibition by substrates and coumarin derivatives. Mol Pharmacol. 1991; 39(1):98-104. PMID: 1987454
21. Munoz FJ, Aldunate R, Inestrosa NC. Peripheral binding site is involved in the neurotrophic activity of acetylcholinesterase. Neuroreport. 1999; 10(17):3621-5. PMID: 10619655
22. Ariel N, Ordentlich A, Barak D, Bino T, Velan B, Shafferman A. The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors. Biochem J. 1998; 335:95-102. PMID: 9742217
23. Tai K, Shen T, Borjesson U, Philippopoulos M, McCammon JA. Analysis of a 10-ns molecular dynamics simulation of mouse acetylcholinesterase. Biophys J. 2001; 81(2):715-24. PMID: 11463620
24. Beck JM, Hadad CM. Reaction profiles of the interaction between sarin and acetylcholinesterase and the S203C mutant: Model nucleophiles and QM/MM potential energy surfaces. Chemico-Biological Interactions. 2010; 187(1-3):220-4.
25. Kovarik Z, Radic Z, Grgas B, Skrinjaric-Spoljar M, Reiner E, Simeon-Rudolf V. Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline. Bba-Protein Struct M. 1999; 1433(1-2):261-71.
26. Sirin GS, Zhang Y. How Is Acetylcholinesterase Phosphonylated by Soman? An Ab Initio QM/MM Molecular Dynamics Study. The Journal of Physical Chemistry A. 2014.
27. Luo CY, Chambers C, Pattabiraman N, Tong M, Tipparaju P, Saxena A. Y124 at the peripheral anionic site is important for the reactivation of nerve agent-inhibited acetylcholinesterase by H oximes. Biochemical pharmacology. 2010; 80(9):1427-36. doi: 10.1016/j.bcp.2010.07.020 PMID: 20655881
28. Colletier JP, Fournier D, Greenblatt HM, Stojan J, Sussman JL, Zaccai G, et al. Structural insights into substrate traffic and inhibition in acetylcholinesterase. Embo Journal. 2006; 25(12):2746-56. PMID: 16763558
29. Bourne Y, Radic Z, Sulzenbacher G, Kim E, Taylor P, Marchot P. Substrate and product trafficking through the active center gorge of acetylcholinesterase analyzed by crystallography and equilibrium binding. J Biol Chem. 2006; 281(39):29256-67. PMID: 16837465
30. Sanson B, Colletier JP, Xu Y, Lang PT, Jiang H, Silman I, et al. Backdoor opening mechanism in acetylcholinesterase based on X-ray crystallography and molecular dynamics simulations. Protein Sci. 2011; 20(7):1114-8. doi: 10.1002/pro.661 PMID: 21594947
31. Gora A, Brezovsky J, Damborsky J. Gates of Enzymes. Chemical Reviews. 2013; 113(8):5871-923. doi: 10.1021/cr300384w PMID: 23617803
32. Ramanathan A, Agarwal PK. Evolutionarily Conserved Linkage between Enzyme Fold, Flexibility, and Catalysis. Plos Biology. 2011;9(11:) .
33. McCammon JA. Gated Diffusion-controlled Reactions. Bmc Biophysics. 2011; 4.
34. Xu YC, Colletier JP, Jiang HL, Silman I, Sussman JL, Weik M. Induced-fit or preexisting equilibrium dynamics? Lessons from protein crystallography and MD simulations on acetylcholinesterase and implications for structure-based drug design. Protein Sci. 2008; 17(4):601-5. doi: 10.1110/ps.083453808 PMID: 18359854
35. Colletier JP, Royant A, Specht A, Sanson B, Nachon F, Masson P, et al. Use of a 'caged' analogue to study the traffic of choline within acetylcholinesterase by kinetic crystallography. Acta Crystallogr D. 2007; 63:1115-28. PMID: 18007027
36. Fang L, Pan Y, Muzyka JL, Zhan C-G. Active Site Gating and Substrate Specificity of Butyrylcholinesterase and Acetylcholinesterase: Insights from Molecular Dynamics Simulations. The Journal of Physical Chemistry B. 2011; 115(27):8797-805. doi: 10.1021/jp112030p PMID: 21682268
37. Xu YC, Colletier JP, Weik M, Jiang HL, Moult J, Silman I, et al. Flexibility of aromatic residues in the active-site gorge of acetylcholinesterase: X-ray versus molecular dynamics. Biophys J. 2008; 95(5):2500-11. doi: 10.1529/biophysj.108.129601 PMID: 18502801
38. Zhou HX, Wlodek ST, McCammon JA. Conformation gating as a mechanism for enzyme specificity. P Natl Acad Sci USA. 1998; 95(16):9280-3. PMID: 9689071
39. Xu Y, Shen J, Luo X, Silman I, Sussman JL, Chen K, et al. How does Huperzine A enter and leave the binding gorge of acetylcholinesterase? Steered molecular dynamics simulations. J Am Chem Soc. 2003; 125:11340. PMID: 16220957
40. Bai F, Xu Y, Chen J, Liu Q, Gu J, Wang X, et al. Free energy landscape for the binding process of Huperzine A to acetylcholinesterase. Proceedings of the National Academy of Sciences. 2013; 110(11):4273-8. doi: 10.1073/pnas.1301814110 PMID: 23440190
41. Niu C, Xu Y, Xu Y, Luo X, Duan W, Silman I, et al. Dynamic mechanism of E202 binding to acetylcholinesterase: A steered molecular dynamics simulation J Phys Chem B. 2005; 109:23730. PMID: 16375354
42. Bui JM, Henchman RH, McCammon JA. The dynamics of ligand barrier crossing inside the acetylcholinesterase gorge. Biophys J. 2003; 85(4):2267-72. PMID: 14507691
43. Van Belle D, De Maria L, Iurcu G, Wodak SJ. Pathways of ligand clearance in acetylcholinesterase by multiple copy sampling. Journal of molecular biology. 2000; 298(4):705-26. PMID: 10788331
44. Gilson MK, Straatsma TP, Mccammon JA, Ripoll DR, Faerman CH, Axelsen PH, et al. Open Back Door in a Molecular-Dynamics Simulation of Acetylcholinesterase. Science. 1994; 263(5151):1276-8. PMID: 8122110
45. Bartolucci C, Perola E, Cellai L, Brufani M, Lamba D. "Back door" opening implied by the crystal structure of a carbamoylated acetylcholinesterase. Biochemistry. 1999; 38(18):5714-9. PMID: 10231521
46. Xu YC, Colletier JP, Weik M, Qin GR, Jiang HL, Silman I, et al. Long Route or Shortcut? A Molecular Dynamics Study of Traffic of Thiocholine within the Active-Site Gorge of Acetylcholinesterase. Biophys J. 2010; 99(12):4003-11. doi: 10.1016/j.bpj.2010.10.047 PMID: 21156143
47. Kronman C, Ordentlich A, Barak D, Velan B, Shafferman A. The "back door" hypothesis for product clearance in acetylcholinesterase challenged by site-directed mutagenesis. J Biol Chem. 1994; 269(45):27819-22. PMID: 7961709
48. Faerman C, Ripoll D, Bon S, LeFeuvre Y, Morel N, Massoulie J, et al. Site-directed mutants designed to test back-door hypotheses of acetylcholinesterase function. Febs Lett. 1996; 386(1):65-71. PMID: 8635606
49. Boyd AE, Dunlop CS, Wong L, Radic Z, Taylor P, Johnson DA. Nanosecond dynamics of acetylcholinesterase near the active center gorge. J Biol Chem. 2004; 279(25):26612-8. PMID: 15078872
50. Greenblatt HM, Guillou C, Guenard D, Argaman A, Botti S, Badet B, et al. The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the activesite gorge: Implications for structure-based drug design. J Am Chem Soc. 2004; 126(47):15405-11. PMID: 15563167
51. Zou Q, Bennion BJ, Daggett V, Murphy KP. The molecular mechanism of stabilization of proteins by TMAO and its ability to counteract the effects of urea. J Am Chem Soc. 2002; 124(7):1192-202. PMID: 11841287
52. Bennion BJ, DeMarco ML, Daggett V. Preventing misfolding of the prion protein by trimethylamine N-oxide. Biochemistry. 2004; 43(41):12955-63. PMID: 15476389
53. Bennion BJ, Daggett V. Counteraction of urea-induced protein denaturation by trimethylamine N-oxide: A chemical chaperone at atomic resolution. P Natl Acad Sci USA. 2004; 101(17):6433-8. PMID: 15096583
54. Kryger G, Harel M, Giles K, Toker L, Velan B, Lazar A, et al. Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. Acta crystallographica Section D, Biological crystallography. 2000; 56(Pt 11):1385-94. PMID: 11053835
55. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The Protein Data Bank. Nucleic Acids Research. 2000; 28(1):235-42. PMID: 10592235
56. Bennion BJ, Lau EY, Fattebert J-L, Huang P, Schwegler E, Corning W, et al. Modeling the Binding of CWAs to AChE and BuChE. Military Medical Science Letters. 2013; 82(3):102-14.
57. Perdew JP, Burke K, Ernzerhof M. Generalized gradient approximation made simple. Physical review letters. 1996; 77(18):3865-8. PMID: 10062328
58. Fattebert JL, Law RJ, Bennion B, Lau EY, Schwegler E, Lightstone FC. Quantitative Assessment of Electrostatic Embedding in Density Functional Theory Calculations of Biomolecular Systems. Journal of Chemical Theory and Computation. 2009; 5(9):2257-64.
59. Fattebert JL, Gygi F. Linear scaling first-principles molecular dynamics with controlled accuracy. Comput Phys Commun. 2004; 162(1):24-36.
60. Sanson B, Nachon F, Colletier JP, Froment MT, Toker L, Greenblatt HM, et al. Crystallographic Snapshots of Nonaged and Aged Conjugates of Soman with Acetylcholinesterase, and of a Ternary Complex of the Aged Conjugate with Pralidoxime. Journal of Medicinal Chemistry. 2009; 52(23):7593-603. doi: 10.1021/jm900433t PMID: 19642642
61. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, et al. Scalable molecular dynamics with NAMD. Journal of Computational Chemistry. 2005; 26(16):1781-802. PMID: 16222654
62. MacKerell AD, Feig M, Brooks CL. Improved treatment of the protein backbone in empirical force fields. J Am Chem Soc. 2004; 126(3):698-9. PMID: 14733527
63. Neria E, Fischer S, Karplus M. Simulation of activation free energies in molecular systems. J Chem Phys. 1996; 105(5):1902-21.
64. Wang J, Cieplak P, Kollman P. How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? JOURNAL OF COMPUTATIONAL CHEMISTRY. 2000; 21(12):1049-74.
65. Ekstrom F, Hornberg A, Artursson E, Hammarstrom LG, Schneider G, Pang YP. Structure of HI-6∗sarin-acetylcholinesterase determined by X-ray crystallography and molecular dynamics simulation: reactivator mechanism and design. PLoS One. 2009; 4(6):e5957. doi: 10.1371/journal.pone.0005957 PMID: 19536291
66. Frishman D, Argos P. Knowledge-based protein secondary structure assignment. Proteins. 1995; 23(4):566-79. PMID: 8749853
67. Habtemariam B, Anisimov VM, MacKerell AD. Cooperative binding of DNA and CBF beta to the Runt domain of the CBF alpha studied via MD simulations. Nucleic Acids Research. 2005; 33(13):4212-22. PMID: 16049027
68. Lee MS, Salsbury FR, Brooks CL. Novel generalized Born methods. J Chem Phys. 2002; 116(24):10606-14.
69. Still WC, Tempczyk A, Hawley RC, Hendrickson T. Semianalytical Treatment of Solvation for Molecular Mechanics and Dynamics. J Am Chem Soc. 1990; 112(16):6127-9.
70. Brooks BR, Brooks CL 3rd, Mackerell AD Jr., Nilsson L, Petrella RJ, Roux B, et al. CHARMM: the biomolecular simulation program. Journal of Computational Chemistry. 2009; 30(10):1545-614. doi: 10.1002/jcc.21287 PMID: 19444816
71. Case DA, Darden TA, Cheatham TE, Simmerling CL, Wang J, Duke RE, et al. AMBER12 and AMBERTOOLS13. San Francisco, CA: Universty of California San Francisco; 2012.
72. Tama F, Sanejouand YH. Conformational change of proteins arising from normal mode calculations. Protein Eng. 2001; 14(1):1-6. PMID: 11287673
73. Krebs WG, Alexandrov V, Wilson CA, Echols N, Yu HY, Gerstein M. Normal mode analysis of macromolecular motions in a database framework: Developing mode concentration as a useful classifying statistic. Proteins. 2002; 48(4):682-95. PMID: 12211036
74. Dvir H, Jiang HL, Wong DM, Harel M, Chetrit M, He XC, et al. X-ray structures of Torpedo californica acetylcholinesterase complexed with (+)-huperzine A and (-)-huperzine B: structural evidence for an active site rearrangement. Biochemistry. 2002; 41(35):10810-8. PMID: 12196020
75. Fuxreiter M, Warshel A. Origin of the catalytic power of acetylcholinesterase: Computer simulation studies. J Am Chem Soc. 1998; 120(1):183-94.
76. Larsson L. The Alkaline Hydrolysis of Isopropoxy-Methyl-Phosphoryl Fluoride (Sarin) and Some Analogues. Acta Chem Scand. 1957; 11(7):1131-42.
77. Zhao Y, Gonzalez-Garcia N, Truhlar DG. Benchmark database of barrier heights for heavy atom transfer, nucleophilic substitution, association, and unimolecular reactions and its use to test theoretical methods. J Phys Chem A. 2005; 109(9):2012-8. PMID: 16833536
78. Sirin GS, Zhou Y, Lior-Hoffmann L, Wang S, Zhang Y. Aging mechanism of soman inhibited acetylcholinesterase. J Phys Chem B. 2012; 116(40):12199-207. doi: 10.1021/jp307790v PMID: 22984913
79. Karlsson E, Mbugua PM, Rodriguez-Ithurralde D. Fasciculins, anticholinesterase toxins from the venom of the green mamba Dendroaspis angusticeps. J Physiol (Paris). 1984; 79(4):232-40. PMID: 6530667
80. Liu JJ, Zhang YK, Zhan CG. Reaction Pathway and Free-Energy Barrier for Reactivation of Dimethyl-phosphoryl- Inhibited Human Acetylcholinesterase. J Phys Chem B. 2009; 113(50):16226-36. doi: 10.1021/jp9055335 PMID: 19924840
81. Michel HO, Hackley BE, Berkowit L, List G, Hackley EB, Gillilan W, et al. Ageing and Dealkylation of Soman (Pinacolylmethylphosphono-Fluoridate)-Inactivated Eel Cholinesterase. Archives of Biochemistry and Biophysics. 1967; 121(1):29-&. PMID: 6068126
82. Shafferman A, Ordentlich A, Barak D, Stein D, Ariel N, Velan B. Aging of phosphylated human acetylcholinesterase: Catalytic processes mediated by aromatic and polar residues of the active centre. Biochem J. 1996; 318:833-40. PMID: 8836126
83. Kovach IM. Stereochemistry and secondary reactions in the irreversible inhibition of serine hydrolases by organophosphorus compounds. J Phys Org Chem. 2004; 17(6-7):602-14.
84. Viragh C, Kovach IM, Pannell L. Small molecular products of dealkylation in soman-inhibited electric eel acetylcholinesterase. Biochemistry. 1999; 38(30):9557-61. PMID: 10423232
85. Carletti E, Li H, Li B, Ekstrom F, Nicolet Y, Loiodice M, et al. Aging of Cholinesterases Phosphylated by Tabun Proceeds through O-Dealkylation. J Am Chem Soc. 2008; 130(47):16011-20. doi: 10.1021/ja804941z PMID: 18975951
86. Artursson E, Andersson PO, Akfur C, Linusson A, Borjegren S, Ekstrom F. Catalytic-site conformational equilibrium in nerve-agent adducts of acetylcholinesterase: Possible implications for the HI-6 antidote substrate specificity. Biochemical pharmacology. 2013; 85(9):1389-97. doi: 10.1016/j.bcp.2013.01.016 PMID: 23376121
87. Ekstrom F, Pang YP, Boman M, Artursson E, Akfur C, Borjegren S. Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: Structural basis for differences in the ability to reactivate tabun conjugates. Biochemical pharmacology. 2006; 72(5):597-607. PMID: 16876764
88. Hornberg A, Artursson E, Warme R, Pang YP, Ekstrom F. Crystal structures of oxime-bound fenamiphos-acetylcholinesterases: Reactivation involving flipping of the His447 ring to form a reactive Glu334-His447-oxime triad. Biochemical pharmacology. 2010; 79(3):507-15. doi: 10.1016/j.bcp.2009. 08.027 PMID: 19732756
89. Trapp M, Trovaslet M, Nachon F, Koza MM, van Eijck L, Hill F, et al. The Energy Landscapes of human Acetylcholinesterase and its Huperzine A-Inhibited Counterpart. The Journal of Physical Chemistry B. 2012.
90. Peters J, Kneller GR. Motional heterogeneity in human acetylcholinesterase revealed by a non-Gaussian model for elastic incoherent neutron scattering. J Chem Phys. 2013; 139(16).
91. Marchot P, Khelif A, Ji YH, Mansuelle P, Bougis PE. Binding of I-125 Fasciculin to Rat-Brain Acetylcholinesterase-the Complex Still Binds Diisopropyl Fluorophosphate. J Biol Chem. 1995; 268(17):12458-67.
92. Eastman J, Wilson EJ, Cervenansky C, Rosenberry TL. Fasciculin-2 Binds to the Peripheral Site on Acetylcholinesterase and Inhibits Substrate Hydrolysis by Slowing a Step Involving Proton-Transfer during Enzyme Acylation. J Biol Chem. 1995; 270(34):19694-701. PMID: 7649979
93. Radic Z, Quinn DM, Vellom DC, Camp S, Taylor P. Allosteric Control of Acetylcholinesterase Catalysis by Fasciculin. J Biol Chem. 1995; 270(35):20391-9. PMID: 7657613